Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 1,697 | 0 | 0 | 0 |
| Gross Profit | 1,697 | N/A | N/A | N/A |
| Operating Expenses | 9,502 | 0 | 0 | 0 |
| Operating Income | -7,805 | N/A | N/A | N/A |
| Other Income | -102 | 0 | 0 | 0 |
| Pre-tax Income | -7,907 | 0 | 0 | 0 |
| Net Income Continuous | -7,907 | N/A | N/A | N/A |
| Net Income | $-7,907 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -17.84 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -18.35 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -17.84 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -18.35 | N/A | N/A | N/A |
| EBITDA(a) | $-7,805 | $N/A | $N/A | $N/A |